Hepatitis Therapeutics Market Size to Reach $19.71 Bn, Globally, by 2030 at 3.1% CAGR | Abbvie, Cipla, Gilead Sciences Inc.

Increase in product approvals and launches, rise in collaborations between major players in the market, and robust presence of pipeline drugs drive the growth of the global hepatitis therapeutics market. However, high cost of hepatitis drugs hinder the market growth. On the other hand, growth opportunities in emerging markets present new opportunities in the coming …